At OSN New York, Nicole R. Fram , MD, talks about the challenges of malpositioned IOLs in the setting of corneal diseases.
Uncategorized
Uncategorized
Study shows different standards of care for cataract patients living in rural vs. urban areas of northern Germany
ATHENS, Greece — A study conducted in Schleswig Holstein, the northernmost federal state of Germany, showed lower standards of care for cataract patients in rural areas compared with urban regions, mainly related to poor and often delayed access to ophthalmological services. “In this part of Germany there are only a few cities surrounded by countryside, where medical services are structurally weaker,” Tim Herbst, MBA, said.
Uncategorized
PRK combined with cross-linking may outperform cross-linking alone for treatment of keratoconus
Topography-guided PRK followed by corneal collagen cross-linking yielded a significantly greater improvement in vision than cross-linking alone in eyes with progressive keratoconus, a study found.Both procedures yielded similarly stable postoperative o…
Second Sight to Discuss Fourth Quarter and Year End 2015 Financial Results on March 3, 2016 Conference Call
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will release its fourth quarter and year end 2…
Clearside Biomedical, Inc. Announces Appointment of Richard J. Croarkin to the Board of Directors
ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, a late-stage clinical biopharmaceutical company developing first-in-class drug therapies for the eye, announces that Richard J. Croarkin is joining its Board of Directors.
Notal Vision Achieves Medicare Coverage For ForeseeHome
CHANTILLY, Va.–(BUSINESS WIRE)–Notal Vision, Inc. is pleased to announce that the ForeseeHome AMD Monitoring Program is now available for eligible Medicare patients across the U.S. ForeseeHome is available by prescription for patients with Dry Age-related Macular Degeneration (AMD) at high risk for developing Wet AMD. The clinical utility for ForeseeHome was established in the Home Monitoring of the Eye (HOME) Study, part of a National Eye Institute-sponsored study, where over 1500 patients w